Infect Control Hosp Epidemiol by See, Isaac et al.
Outbreak of Clostridium difficile Infections at an Outpatient 
Hemodialysis Facility—Michigan, 2012–2013
Isaac See, MD1,2, Suparna Bagchi, DrPH1,3, Stephanie Booth, AHA, CCHT4, Daniel Scholz, 
MD5, Andrew I. Geller, MD1,2, Lydia Anderson, BS2, Heather Moulton-Meissner, PhD2, 
Jennie L. Finks, DVM, MVPH6, Karen Kelley, MHA, BSN4, Carolyn V. Gould, MD2, and Priti 
R. Patel, MD, MPH2
1Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA
2Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, 
GA
3Kansas Department of Health, Topeka, KS
4Portage Health Dialysis, Portage Health, Hancock, MI
5Department of Emergency Medicine, Mayo Clinic, Rochester, MN
6Michigan Department of Community Health, Lansing, MI
Abstract
Investigation of an outbreak of Clostridium difficile infection (CDI) at a hemodialysis facility 
revealed evidence that limited intra-facility transmission occurred despite adherence to published 
infection control standards for dialysis clinics. Outpatient dialysis facilities should consider CDI 
prevention, including environmental disinfection for C. difficile, when formulating their infection 
control plans.
Introduction
Although dialysis patients have increased risk for Clostridium difficile infection (CDI)1,2 
outbreaks within outpatient hemodialysis facilities have not been described previously. We 
describe the first reported CDI outbreak at an outpatient hemodialysis facility and 
subsequent investigations to assess for potential intrafacility transmission and evaluate risk 
factors for CDI.
Methods
A CDI case was defined as an incident diarrheal illness (self-reported or observed loose 
stool) during October 2012–March 2013 associated with a positive C. difficile test (Xpert C. 
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difficile, Cepheid) in a hemodialysis facility patient. A subsequent CDI episode was defined 
as diarrheal illness associated with a positive C. difficile test occurring after ≥ 2 weeks. 
Cases were identified from dialysis facility, local nursing home, and hospital records.
Cases with outpatient onset of diarrhea or onset before day 4 of a hospitalization were 
considered community-onset. Community-onset cases with an overnight hospital stay within 
12 weeks prior to CDI were classified as hospital-associated; others were community-
associated.
Patients dialyzed at the facility during October 2012–March 2013 were included in a cohort 
study. Potential risk factors for incident CDI were assessed through patient interview and 
chart review.
To screen for C. difficile carriage or undetected infection among patients not reporting 
diarrheal symptoms, stool samples from patients not receiving treatment for CDI were tested 
using a polymerase chain reaction assay (Xpert C. difficile). Twenty-five of 29 eligible 
patients were screened. Specimens testing positive were cultured for C. difficile. Recovered 
isolates underwent pulsed-field gel electrophoresis (PFGE). Facility staff were asked to 
report symptoms of diarrheal illness but did not undergo laboratory screening.
Environmental samples from high-touch surfaces within the facility and from healthcare 
personnel’s hands were obtained and cultured for C. difficile. The dialysis facility’s infection 
control practices were observed, including hand hygiene, personal protective equipment use, 
and environmental disinfection practices.
Statistical analysis was performed with SAS, version 9.3. Categorical variables were 
compared using Chi-squared or Fisher’s exact test. Continuous variables were compared 
with a Wilcoxon Rank-Sum test. P values ≤ 0.05 were considered significant.
Results
Between October 2012 and March 2013, 37 outpatients were dialyzed at the facility, a 
hospital-based outpatient hemodialysis clinic. No hospital inpatients were dialyzed at the 
hemodialysis clinic. Six patients developed incident CDI; 5 (83%) also developed a 
subsequent CDI episode. All cases were community-onset; three were hospital-associated, 
from the same hospital. The three community-associated case-patients had not received 
antibiotics within 12 weeks before illness onset and had no common healthcare exposures 
other than hemodialysis.
One facility staff member with recent prior antibiotic exposure developed laboratory-
confirmed CDI after caring for the first symptomatic case-patient. This staff member’s only 
healthcare exposures within the 12 weeks prior consisted of outpatient clinic visits and 
antibiotic exposure. No clear epidemiologic links were found between this staff member and 
subsequent cases.
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Two additional patients who initially denied having diarrhea screened positive for C. 
difficile and were CDI cases based on consistency of stool collected for screening. 
Therefore, 8 of 37 patients at the facility developed CDI (attack rate: 22%).
Antibiotics were received by 44.1% of patients in the cohort, and 35.1% were hospitalized 
within the prior 12 weeks. Hospitalization within the prior 30 days (P=0.05) and non-fistula 
dialysis access (i.e., arteriovenous graft or hemodialysis catheter) (P=0.01) were significant 
risk factors for CDI in univariate analysis (Table 1). Prior antibiotic use overall was not a 
significant risk factor for CDI but use of β-lactam agents was (P=0.05). All case-patients 
receiving β-lactam agents had a non-fistula access and were diagnosed with sepsis within the 
prior 4 weeks.
C. difficile isolates were recovered from six case-patients: one hospital-associated, three 
community-associated, and two screen-positive. The hospital-associated case isolate’s PFGE 
pattern was indistinguishable from that of a community-associated case that occurred one 
week later (both North American Pulse Field type 4). These two case-patients did not have 
the same dialysis schedule or station. However, they both received dialysis at the facility 
throughout the 12 weeks prior to the later case’s illness onset. The other four isolates’ PFGE 
types were unrelated to each other. No isolate from the affected staff member was available 
for analysis. C. difficile was not recovered from environmental (n=39) or hand (n=10) 
samples.
In accordance with infection control guidelines for hemodialysis facilities, staff were 
required to wear gloves during patient contact and to wait until the station was unoccupied 
before beginning routine disinfection3,4. Prior to this outbreak, the facility was using a 1:100 
dilution of chlorine bleach for routine environmental surface disinfection after dialysis 
sessions. Initial response measures included designating three dialysis stations as CDI 
contact isolation stations for all CDI patients. Staff were required to don a dedicated, 
disposable gown and gloves while caring for a patient in contact isolation and to wash hands 
with soap and water afterwards. In addition, a 1:10 dilution of bleach was used to disinfect 
environmental surfaces in stations after treatment of CDI patients.
During infection prevention practice audits, hand hygiene was performed during 127 (89%) 
of 143 opportunities. The wet contact time of bleach was often less than manufacturer’s 
recommendations. Additionally, on some occasions patients without CDI were dialyzed at 
contact isolation stations.
The facility instituted additional control measures after these audits, including heightened 
diligence to ensure adequate wet contact time of bleach on surfaces. Contact isolation 
stations were dedicated exclusively for CDI patients, and patients were maintained in 
contact isolation until 2 weeks after completion of CDI antibiotic treatment. As of June 
2013, no new CDI cases had occurred.
Discussion
We describe an outbreak of CDI within a hemodialysis facility with high attack rate and 
recurrence rate. Many affected patients lacked classic risk factors (i.e., half had neither prior 
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recent hospitalization nor recent antibiotic use). Available epidemiologic and laboratory data 
suggest likely intrafaciliy transmission of C. difficile to at least one patient, despite observed 
hand hygiene adherence of nearly 90%. Transmission to the healthcare worker at the facility 
also may have occurred given the temporal association. The two case-patients with 
indistinguishable C. difficile isolates (by PFGE) lacked direct overlap with one another in 
space and time, suggesting indirect transmission between these two case-patients.
The shared patient environment and lack of physical barriers between stations in outpatient 
dialysis facilities might facilitate transmission of C. difficile. Infection control 
recommendations for hemodialysis clinics lack specific recommendations for C. difficile, 
but contain suggestions that could be relevant for CDI (e.g., wear a dedicated gown when 
caring for patients with uncontrolled diarrhea)4. The facility’s response to this outbreak 
extended beyond these recommendations, e.g., dedicating certain dialysis stations for CDI 
patients and extending the duration of contact isolation.
We found that presence of an arteriovenous fistula was protective. Although this association 
of CDI with non-fistula access types could be a marker for underlying patient comorbidity, 
fistula patients might actually have lower risk and national efforts to reduce access-related 
infections in this dialysis patients5,6 might have secondary benefits in terms of reduced 
antibiotic exposure, hospitalizations, and CDI risk.
Unlike in a prior study7, Charlson index was not associated with CDI, and serum albumin 
levels were not available to evaluate. Other known CDI risk factors were common: nearly 
half of the patients had recently used antibiotics, and about one-third had recent 
hospitalizations. Though antibiotic use in general was not a significant risk factor, use of β-
lactam agents was.
Limitations with this investigation include the relatively small number of cases, reliability of 
patients’ self-reports, and availability of C. difficile isolates. Finally, increased attention to 
environmental cleaning prior to sample collection may have limited recovery of C. difficile 
from environmental samples.
In summary, CDI transmission within an outpatient dialysis facility can occur. Outpatient 
dialysis facilities should routinely adhere to practices that reduce the burden and risk of 
environmental contamination3–4,8 and consider CDI prevention when developing an 
infection control plan.
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